Literature DB >> 22906551

Prevalence and distinguishing features of masked hypertension in type 2 diabetic patients.

Jianguang Zhou1, Changyun Liu, Peijia Shan, Yingqi Zhou, Erli Xu, Yufeng Ji.   

Abstract

OBJECTIVE: The prevalence and clinical features of masked hypertension (MH) in type 2 diabetes mellitus patients (T(2)DM) were investigated to define clinical indices which may aid diagnosis and treatment.
METHODS: Clinical blood pressure (CBP) and ambulatory blood pressure (ABP) were measured in 856 T(2)DM patients to differentiate normotensive (NT), essential hypertensive (EH), and MH. Waist circumference (WC), abdominal circumference (AC), body mass index (BMI), waist to height ratio (WHtR), fasting blood glucose (FBG), and glycated hemoglobin levels were measured and compared between BP groups.
RESULTS: In total, 359 patients had normal CBP, of which 13.37% were diagnosed with MH based on established criteria. Males had significantly higher rates of MH (15.30%) than females (11.36%) (P=0.036). The MH detection rate increased with age and T(2)DM duration. There were no significant differences in BMI, WC or WHtR between total MH and EH groups. MH females, however, had lower BMIs than female EH females (P=0.023). Smoking, alcohol, and familial EH history were lower in MH than EH patients (smoking, P=0.029; alcohol ,P=0.001; and EH history, P=0.000), while BMI (male, P=0.037, female, P=0.015), WC (male, P=0.012, female, P=0.021), WHtR (P=0.011), smoking (P=0.016), and alcohol consumption (P=0.000) were higher in MH than NT patients. BMI, WHtR, 6-15 year disease course of diabetes, smoking and alcoholism were independent risk factors of T(2)DM complicated with MH. The dipper BP circadian pattern was significantly lower in MH than NT patients (P=0.001). The non-dipper pattern was lower in MH than EH (P=0.018) but higher than in NT (P=0.000).
CONCLUSIONS: A significant fraction of T(2)DM patients were diagnosed with MH. Clinical presentation also contrasted sharply from EH, MH is a specific blood pressure status that may severely damage target organs in T(2)DM.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22906551     DOI: 10.1016/j.jdiacomp.2012.07.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Authors:  Amita Singh; Eugenia Gianos; Arthur Schwartzbard; Henry Black; Howard Weintraub
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

Review 2.  Alcohol and Hypertension-New Insights and Lingering Controversies.

Authors:  Ian B Puddey; Trevor A Mori; Anne E Barden; Lawrence J Beilin
Journal:  Curr Hypertens Rep       Date:  2019-09-07       Impact factor: 5.369

3.  The impact of different anthropometric measures on sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension in patients with type 2 diabetes.

Authors:  Baris Afsar
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09-13

4.  Correlation between the levels of serum cystatin C and substance P in peripheral blood in diabetes mellitus patients complicated with hypertension.

Authors:  Wei Zhu; Xuelian Gong; Chao Luo; Jing Lu
Journal:  Exp Ther Med       Date:  2018-06-11       Impact factor: 2.447

5.  Masked nocturnal hypertension as a result of high prevalence of non-dippers among apparently well-controlled hypertensive patients with type 2 diabetes mellitus: data from a prospective study.

Authors:  Pop Călin; Manea Viorel; Pruna Luchiana; Cosma Mihaela; Pop Lavinia
Journal:  Diabetol Metab Syndr       Date:  2022-09-15       Impact factor: 5.395

6.  Masked hypertension in diabetes mellitus: treatment implications for clinical practice.

Authors:  Stanley S Franklin; Lutgarde Thijs; Yan Li; Tine W Hansen; José Boggia; Yanping Liu; Kei Asayama; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Jan Filipovsky; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2013-03-11       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.